The latest firm to top up its venture capital coffers is Austin, Texas-based Santé Ventures, which on Monday announced its ...

Exxel Pharma is eyeing a listing on the NYSE American to fund human trials for a drug class that has previously struggled to ...

In a stock market currently obsessed with interest rate cuts and the artificial intelligence (AI) boom, it is easy to ...

A major biotech company has announced plans to lay off more than 100 positions from its Franklin, Massachusetts, facility.

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

A surge in Inventiva shares, up about 50% in the first few weeks of 2026, highlights investors' appetite for ​betting on the ...

A large biotech fund that's an insider at Cogent Biosciences recently sold millions of shares amid the company's best annual ...

Krystal Biotech, Inc. (NASDAQ:KRYS) is one of the 10 best NASDAQ growth stocks to buy for the next 10 years. Andrea Tan, an ...

The business may not be as strong as its performance this year suggests.

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

Stay updated on biotech layoffs in 2026! Each week, we track and analyze industry layoffs, their causes, and their impact.

Legend Biotech (LEGN) has drawn investor attention after a sharp share price pullback, with the stock down about 20% over the past month and roughly 46% over the past 3 months. See our latest analysis ...